These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12600417)

  • 61. Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA).
    Whitehouse PA; Knight LA; Di Nicolantonio F; Mercer SJ; Sharma S; Cree IA;
    Anticancer Drugs; 2003 Jun; 14(5):369-75. PubMed ID: 12782944
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro evaluation of the novel chemotherapeutic agents U-73,975, U-77,779, and U-80,244 in gynecologic cancer cell lines.
    Hightower RD; Sevin BU; Perras J; Nguyen H; Angioli R; Untch M; Averette H
    Cancer Invest; 1993; 11(3):276-82. PubMed ID: 8485650
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
    Thigpen T; Vance RB; Khansur T
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparison of three assays used for the in vitro chemosensitivity testing of human tumours.
    Wilson AP; Ford CH; Newman CE; Howell A
    Br J Cancer; 1984 Jan; 49(1):57-63. PubMed ID: 6197986
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Establishment of transplantable human colon cancer cell lines, chemosensitivity of colon carcinomas and the serially transplantable strains with MTT assay].
    Kase S; Kubota T; Furukawa T; Yamaguchi H; Takeuchi T; Takahara T; Suto A; Kodaira S; Ishibiki K
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2247-53. PubMed ID: 1929445
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
    Schadendorf D; Worm M; Algermissen B; Kohlmus CM; Czarnetzki BM
    Cancer; 1994 Jan; 73(1):103-8. PubMed ID: 7506115
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms.
    Koechli OR; Schaer GN; Sevin BU; Perras JP; Schenk V; Rodriguez M; Untch M; Steren A; Haller U
    Anticancer Drugs; 1995 Feb; 6(1):94-100. PubMed ID: 7756689
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy.
    Wilson JK; Sargent JM; Elgie AW; Hill JG; Taylor CG
    Br J Cancer; 1990 Aug; 62(2):189-94. PubMed ID: 2386733
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations.
    Qiu F; Zhao X
    J BUON; 2018; 23(1):117-123. PubMed ID: 29552770
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemosensitivity testing in malignant melanoma.
    Ugurel S; Tilgen W; Reinhold U
    Recent Results Cancer Res; 2003; 161():81-92. PubMed ID: 12528801
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells.
    Ohta I; Gorai I; Miyamoto Y; Yang J; Zheng JH; Kawata N; Hirahara F; Shirotake S
    Cancer Lett; 2001 Jan; 162(1):39-48. PubMed ID: 11121861
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.
    Ford CH; Richardson VJ; Tsaltas G
    Cancer Chemother Pharmacol; 1989; 24(5):295-301. PubMed ID: 2788039
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical usefulness of chemosensitivity test for advanced colorectal cancer.
    Kabeshima Y; Kubota T; Watanabe M; Hasegawa H; Furukawa T; Kitajima M
    Anticancer Res; 2002; 22(5):3033-7. PubMed ID: 12530038
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
    Gerçel-Taylor C; Ackermann MA; Taylor DD
    Anticancer Res; 2001; 21(4A):2761-8. PubMed ID: 11724352
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.
    Flick MB; O'Malley D; Rutherford T; Rodov S; Kamsteeg M; Hao XY; Schwartz P; Kacinski BM; Mor G
    J Soc Gynecol Investig; 2004 May; 11(4):252-9. PubMed ID: 15120700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Study of small-cell lung cancer cell-based sensor and its applications in chemotherapy effects rapid evaluation for anticancer drugs.
    Guohua H; Hongyang L; Zhiming J; Danhua Z; Haifang W
    Biosens Bioelectron; 2017 Nov; 97():184-195. PubMed ID: 28599178
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
    Fricker SP; Buckley RG
    Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay].
    Untch M; Sevin BU; Untch A; Konecny G; Nestle-Krämling C; Korell M; Hepp H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():311-3. PubMed ID: 7906979
    [No Abstract]   [Full Text] [Related]  

  • 80. Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma.
    Gronlund B; Hansen HH; Høgdall C; Engelholm SA
    Cancer; 2002 Oct; 95(8):1656-62. PubMed ID: 12365013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.